Hormone Therapy and Skin Health: How Estrogen and Testosterone Affect Aging Skin

Your Skin Is a Hormone Organ

The skin is often considered purely cosmetic — a surface-level concern separate from “real” health. But the skin is the body’s largest organ, and it is densely populated with estrogen, androgen, and growth hormone receptors that govern its thickness, elasticity, hydration, wound healing, and aging rate. When hormone levels decline in midlife, the effects on skin are among the most visually apparent manifestations of hormonal change — and one of the most convincing arguments patients cite for seeking hormone therapy.

Estrogen and Skin: The Collagen Connection

Estrogen is the primary hormone governing skin structure and quality. Estrogen receptors in skin fibroblasts (connective tissue cells) respond to estrogen by stimulating collagen synthesis, hyaluronic acid production, and skin cell proliferation. The clinical consequences of estrogen loss are substantial and well-documented:

• Collagen loss: Women lose approximately 30% of skin collagen in the first 5 years after menopause — significantly more than the 1% per year lost during premenopausal aging. This produces thinning, sagging, and increased wrinkling far more rapidly than chronological aging alone.
• Hyaluronic acid decline: Estrogen supports hyaluronic acid production in the dermal matrix. Its decline reduces skin moisture retention, producing dryness, dullness, and increased appearance of fine lines.
• Reduced vascularity: Estrogen supports cutaneous microcirculation. Loss reduces the nutrient and oxygen supply to skin cells, contributing to pallor, reduced wound healing, and accelerated aging.
• Reduced elastin: Estrogen supports elastin fiber integrity, maintaining skin’s ability to return to shape after movement. Elastin degradation with estrogen loss contributes to laxity and crepiness.

HRT in postmenopausal women has been shown in multiple controlled trials to significantly slow these changes — preserving collagen content, improving skin thickness, and reducing fine line depth. The earlier HRT is initiated, the greater the preservation of skin quality.

Testosterone and Skin

Testosterone in both men and women regulates sebaceous gland activity, skin thickness, and body hair distribution. In men, declining testosterone with age contributes to reduced sebum production (producing drier skin), thinning skin, and reduced wound healing capacity. In women, testosterone supports skin thickness and turgor — contributing to why low testosterone produces a “thin,” easily bruised quality to skin alongside other deficiency symptoms.

Testosterone therapy has shown skin quality benefits including improved skin thickness, increased sebum (improving dry skin), and in some studies, improved collagen content — though these effects are less well-studied than estrogen’s documented skin effects.

Growth Hormone and Skin

IGF-1 (the primary mediator of GH’s tissue effects) stimulates fibroblast proliferation, collagen synthesis, and skin cell renewal. GH decline contributes to the thinning, wrinkling, and reduced elasticity of aging skin — and restoration of GH axis function through sermorelin/ipamorelin peptide protocols produces gradual but noticeable skin quality improvements over months of therapy, including improved texture, reduced fine lines, and better wound healing.

A Comprehensive Approach to Skin Aging Through Hormone Optimization

While topical skincare (retinoids, vitamin C, sunscreen) addresses skin aging from the outside, hormone optimization addresses it from within — providing the biological signals that skin cells require to maintain their structure and function. At Multigen Wellness, skin health is one of the documented quality-of-life benefits patients frequently report alongside the more commonly discussed energy, libido, and mood improvements from hormone therapy.

For hormone optimization that supports your skin, health, and vitality simultaneously, call Multigen Wellness at (800) 259-0015.